Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
CDC Scientific Publications on COVID-19
Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page:
About CDC.gov
.
COVID-19 CDC Publications Database
Last data update: May 13, 2024
. (Total:
1930
publications since 2020)
(Author names in bold with hyperlink are CDC authors)
Filtered By:
Select to fine-tune your search
Publication Topic
CDC Author
Year
Journal
Order By:
Publication Date
Altmetric Score
Records 1-3 (of 3 Records)
Query Trace:
Ciesla AA[original query]
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R
,
Ciesla AA
,
Roper LE
,
Scobie HM
,
Ali AR
,
Miller JD
,
Wiegand RE
,
Accorsi EK
,
Verani JR
,
Shang N
,
Derado G
,
Britton A
,
Smith ZR
,
Fleming-Dutra KE
.
MMWR Morb Mortal Wkly Rep 2023 72 (5) 119-124
Similar articles in PubMed
DOI:
10.15585/mmwr.mm7205e1
Preliminary estimates of effectiveness of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection among children aged 3-5 years - increasing community access to testing program, United States, July 2022-February 2023
Fleming-Dutra KE
,
Ciesla AA
,
Roper LE
,
Smith ZR
,
Miller JD
,
Accorsi EK
,
Verani JR
,
Shang N
,
Derado G
,
Wiegand RE
,
Pilishvili T
,
Britton A
,
Link-Gelles R
.
MMWR Morb Mortal Wkly Rep 2023 72 (7) 177-182
Similar articles in PubMed
DOI:
10.15585/mmwr.mm7207a3
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
Link-Gelles R
,
Ciesla AA
,
Fleming-Dutra KE
,
Smith ZR
,
Britton A
,
Wiegand RE
,
Miller JD
,
Accorsi EK
,
Schrag SJ
,
Verani JR
,
Shang N
,
Derado G
,
Pilishvili T
.
MMWR Morb Mortal Wkly Rep 2022 71 (48) 1526-1530
Similar articles in PubMed
DOI:
10.15585/mmwr.mm7148e1
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
May 13, 2024
Content source:
Office of Genomics and Precision Public Health
,
CDC Office of Science
Powered by CDC PHGKB Infrastructure
TOP